Insider holders · CIK 0001806952
Lyell Immunopharma, Inc. · LYEL
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Innovative Cellular Therapeutics Holdings Ltd10% Owner | 2,774,980 | — | 2,774,980 | Jul 27, 2026 · 9:14 pm EDT | Form 4 |
| Richard KlausnerDirector | 148,391 | 42,166 | 190,557 | Jun 12, 2026 · 4:21 pm EDT | Form 4 |
| Lynn SeelyPresident and CEO | 63,899 | — | 63,899 | Aug 25, 2026 · 4:06 pm EDT | Form 4 |
| David ShookChief Medical Officer | 20,423 | — | 20,423 | Sep 10, 2026 · 7:37 pm EDT | Form 4 |
| Jarrad Mattieu AguirreChief Medical Officer | 20,279 | — | 20,279 | Sep 10, 2026 · 7:31 pm EDT | Form 4 |
| Stephen J. HillChief Operating Officer | 16,816 | — | 16,816 | Aug 25, 2026 · 4:05 pm EDT | Form 4 |
| Gary K. LeeChief Scientific Officer | 16,220 | — | 16,220 | Aug 25, 2026 · 4:03 pm EDT | Form 4 |
| Veronica Sanchez BulisVP, Corporate Controller | 14,799 | — | 14,799 | Aug 11, 2026 · 4:21 pm EDT | Form 4 |
| Sumant RamachandraDirector | — | 10,000 | 10,000 | Jun 12, 2026 · 4:23 pm EDT | Form 4 |
| Cathy FriedmanDirector | — | 5,000 | 5,000 | Jun 12, 2026 · 4:19 pm EDT | Form 4 |
| Otis W BrawleyDirector | 1,782 | — | 1,782 | Jun 12, 2026 · 4:17 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.